In a study conducted across 16 countries and published in the current issue of JAMA Psychiatry, Harris et al1 report (1) a lifetime prevalence of DSM-IV major depressive disorder (MDD)—ascertained by lay interviewers—ranging more than 5-fold across low- and middle-income countries (LMICs) (from 2.9% to 16.9%) and high-income countries (HICs) (from 3.0% to 16.7%); (2) percentages of patients with MDD stating that they ever obtained treatment ranging from 7.0% to 35.7% across LMICs and from 23.8% to 56.2% across HICs; and (3) a proportion of these latter patients indicating that treatment had been “helpful” ranging from 34.6% to 76.0% across LMICs and from 46.5% to 90.7% across HICs.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Maj M. Helpful Treatment of Depression—Delivering the Right Messages. JAMA Psychiatry. Published online May 20, 2020. doi:10.1001/jamapsychiatry.2020.0363
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: